Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Lexington, KY
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Lafayette, LA
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Women's & Children's Hospital
mi
from
Lafayette, LA
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
New Orleans, LA
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Ochsner Health System
mi
from
New Orleans, LA
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Shreveport, LA
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Willis-Knighton Physicians Network
mi
from
Shreveport, LA
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Long Branch, NJ
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Monmouth Medical Center
mi
from
Long Branch, NJ
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Johnson City, NY
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
UHS - Wilson Medical Center
mi
from
Johnson City, NY
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Niskayuna, NY
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Bellevue Woman's Center of Ellis Medicine
mi
from
Niskayuna, NY
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Cincinnati, OH
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Toledo, OH
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Toledo Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
West Reading, PA
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
The Reading Hospital and Medical Center
mi
from
West Reading, PA
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Charleston, SC
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Chattanooga, TN
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Erlanger
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Austin, TX
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
St. David's Medical Center
mi
from
Austin, TX
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Austin, TX
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
North Austin Medical Center - St. David's Women's Center of Texas
mi
from
Austin, TX
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Houston, TX
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated:  8/31/2012
mi
from
Salt Lake City, UT
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program
Status: Enrolling
Updated: 8/31/2012
St. Mark's Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated:  9/3/2012
mi
from
Iowa City, IA
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated: 9/3/2012
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated:  9/3/2012
mi
from
Eugene, OR
Cognitive Behavioral Therapy Delivered Over the Internet for Women With Postpartum Depression
Web-Based Cognitive Behavioral Intervention for Women With Postpartum Depression
Status: Enrolling
Updated: 9/3/2012
Oregon Research Institute
mi
from
Eugene, OR
Click here to add this to my saved trials
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
The Effects of Short Term Growth Hormone Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity
Status: Enrolling
Updated:  9/6/2012
mi
from
Boston, MA
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
The Effects of Short Term Growth Hormone Treatment on Skeletal Muscle Phosphocreatine Recovery in Obesity
Status: Enrolling
Updated: 9/6/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of ATNC05 in Reducing Back Pain Compared With Placebo
ATNC05, A Composition to Reduce Back Pain, A Proof-of-Concept, Randomized, Double-Blind - Placebo Controlled Study
Status: Enrolling
Updated:  9/12/2012
mi
from
North Miami, FL
Efficacy of ATNC05 in Reducing Back Pain Compared With Placebo
ATNC05, A Composition to Reduce Back Pain, A Proof-of-Concept, Randomized, Double-Blind - Placebo Controlled Study
Status: Enrolling
Updated: 9/12/2012
Annette C. Toledano MD
mi
from
North Miami, FL
Click here to add this to my saved trials
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
Status: Enrolling
Updated:  9/19/2012
mi
from
Tampa, FL
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
Using a Sheathed Speculum to Visualize and Access the Cervix In Women With Excessive Vaginal Tissue
Status: Enrolling
Updated: 9/19/2012
USF STC
mi
from
Tampa, FL
Click here to add this to my saved trials
Clinical Evaluation of Polarized Light Assisted Colposcopy
Clinical Evaluation of Polarized Light Assisted Colposcopy
Status: Enrolling
Updated:  9/25/2012
mi
from
Augusta, GA
Clinical Evaluation of Polarized Light Assisted Colposcopy
Clinical Evaluation of Polarized Light Assisted Colposcopy
Status: Enrolling
Updated: 9/25/2012
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Regadenoson Real Time Perfusion Imaging Trial-Optison
Regadenoson Real Time Perfusion Imaging Trial-Optison
Status: Enrolling
Updated:  9/25/2012
mi
from
Rochester, MN
Regadenoson Real Time Perfusion Imaging Trial-Optison
Regadenoson Real Time Perfusion Imaging Trial-Optison
Status: Enrolling
Updated: 9/25/2012
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Regadenoson Real Time Perfusion Imaging Trial-Optison
Regadenoson Real Time Perfusion Imaging Trial-Optison
Status: Enrolling
Updated:  9/25/2012
mi
from
Omaha, NE
Regadenoson Real Time Perfusion Imaging Trial-Optison
Regadenoson Real Time Perfusion Imaging Trial-Optison
Status: Enrolling
Updated: 9/25/2012
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates
Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates
Status: Enrolling
Updated:  10/15/2012
mi
from
New York, NY
Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates
Hospital-Based Phthalate Exposure in Very Low Birth Weight Neonates
Status: Enrolling
Updated: 10/15/2012
Mount Sinai Hospital Neonatal Intensive Care Unit
mi
from
New York, NY
Click here to add this to my saved trials
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated:  10/16/2012
mi
from
Cincinnati, OH
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated: 10/16/2012
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated:  10/16/2012
mi
from
Cincinnati, OH
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated: 10/16/2012
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Los Angeles, CA
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
MCS Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Opa-Locka, FL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Sunshine Research Center
mi
from
Opa-Locka, FL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
West Palm Beach, FL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Altus Rsearch,INC
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Addison, IL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Provident Clincal Research
mi
from
Addison, IL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Lexington, KY
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Central Kentucky Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Irondequoit, NY
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Rochester Clinical Research
mi
from
Irondequoit, NY
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Winston-Salem, NC
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
PGM Research of Winston-Salem, LLC
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Johnston, RI
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Corsicana, TX
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Corsicana Medical Research,PNC
mi
from
Corsicana, TX
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
mi
from
Richmond, VA
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Support Fetal Heart Rate and Uterine Contraction for Preterm Labor in Singleton and Multiple Pregnancies
Study to Determine the Equivalence of the Monica AN24 Monitor to Predicate Devices for (FHR) and (UC) During Pre-term Labor and Multiples
Status: Enrolling
Updated:  10/23/2012
mi
from
New York, NY
Study to Support Fetal Heart Rate and Uterine Contraction for Preterm Labor in Singleton and Multiple Pregnancies
Study to Determine the Equivalence of the Monica AN24 Monitor to Predicate Devices for (FHR) and (UC) During Pre-term Labor and Multiples
Status: Enrolling
Updated: 10/23/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
Assessment of Emerging Technology: Comparison of Breast Tomosynthesis and Digital Mammography in the Evaluation of Heterogeneously Dense and Extremely Dense Breasts
Status: Enrolling
Updated:  10/30/2012
mi
from
Ann Arbor, MI
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
Assessment of Emerging Technology: Comparison of Breast Tomosynthesis and Digital Mammography in the Evaluation of Heterogeneously Dense and Extremely Dense Breasts
Status: Enrolling
Updated: 10/30/2012
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Healthy Eating for Reproductive Health (HERHealth)
Healthy Eating for Reproductive Health (HERHealth)
Status: Enrolling
Updated:  11/2/2012
mi
from
West Columbia, SC
Healthy Eating for Reproductive Health (HERHealth)
Healthy Eating for Reproductive Health (HERHealth)
Status: Enrolling
Updated: 11/2/2012
University of South Carolina
mi
from
West Columbia, SC
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Birmingham, AL
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Cullman, AL
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Cullman, AL
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Phoenix, AZ
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Scottsdale, AZ
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Phoenix, AZ
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Tucson, AZ
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Beverly Hills, CA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Encinitas, CA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
Fountain Valley, CA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated:  11/8/2012
mi
from
La Jolla, CA
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Prospective, Observational Trial Evaluating Xeomin®(incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Status: Enrolling
Updated: 11/8/2012
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials